| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.87▼ | 8.89▼ | 8.90▼ | 8.69▲ | 8.27▲ |
| MA10 | 8.88▼ | 8.90▼ | 8.88▼ | 8.55▲ | 8.45▲ |
| MA20 | 8.88▼ | 8.83▲ | 8.78▲ | 8.40▲ | 8.82▲ |
| MA50 | 8.79▲ | 8.58▲ | 8.57▲ | 8.46▲ | 17.06▼ |
| MA100 | 8.59▲ | 8.41▲ | 8.34▲ | 9.03▼ | 19.84▼ |
| MA200 | 8.43▲ | 8.32▲ | 8.46▲ | 15.73▼ | 25.37▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | -0.011▼ | -0.005▼ | 0.077▲ | 0.515▲ |
| RSI | 52.143▲ | 55.874▲ | 56.569▲ | 58.054▲ | 40.542▼ |
| STOCH | 13.056▼ | 57.870 | 73.452 | 76.950 | 44.111 |
| WILL %R | -91.667▼ | -61.111 | -21.154▲ | -8.108▲ | -30.823 |
| CCI | -79.154 | -8.061 | 24.792 | 143.725▲ | 65.183 |
|
Monday, January 26, 2026 04:00 PM
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL). Such investors are advised to ...
|
|
Wednesday, October 29, 2025 03:57 AM
The average one-year price target for Instil Bio (NasdaqCM:TIL) has been revised to $97.66 / share. This is an increase of 41.50% from the prior estimate of $69.02 dated September 27, 2025. The price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/04/26 | 8.90 | 8.98 | 8.6201 | 8.88 | 19,422 |
| 16/04/26 | 8.97 | 8.97 | 7.93 | 8.90 | 13,426 |
| 15/04/26 | 8.39 | 9.00 | 8.39 | 8.89 | 81,895 |
| 14/04/26 | 8.43 | 8.50 | 8.2568 | 8.44 | 15,956 |
| 13/04/26 | 8.16 | 8.48 | 7.9001 | 8.355 | 27,768 |
| 10/04/26 | 8.30 | 8.50 | 7.935 | 8.11 | 23,397 |
| 09/04/26 | 8.24 | 8.50 | 8.17 | 8.475 | 15,463 |
| 08/04/26 | 8.61 | 8.70 | 8.46 | 8.54 | 36,429 |
| 07/04/26 | 8.37 | 8.50 | 8.30 | 8.45 | 46,076 |
| 06/04/26 | 7.92 | 8.50 | 7.71 | 8.46 | 66,002 |
|
|
||||
|
|
||||
|
|